[Respiratory effects of almitrine on various levels of the fraction of inspired oxygen. A study in the anesthetized dog].
The effects of intravenous almitrine under normoxic, hyperoxic, and hypoxic conditions were studied in 5 male beagle dogs (mean weight 15.2 +/- 5 kg) anaesthetized with thiopentone. Plasma concentrations of thiopentone were maintained constant at 27-29 mg.1(-1). Each animal underwent twice the three different experiments, with a lapse of a fortnight between each experiment: a) breathing room air, with intravenous administration of 1 mg.kg-1 almitrine over 30 s, b) breathing room air, then pure oxygen for 15 min, followed by an intravenous administration of 1 mg.kg-1 almitrine over 30 s with the dog still breathing pure oxygen, and c) breathing room air, then progressively less oxygen (FIO2 0.18, 0.16, 0.14, 0.12 for 5 min each), followed by an intravenous administration of 1 mg.kg-1 almitrine over 30 s with the dog still breathing a mixture with 12% oxygen. Tidal volume, respiratory rate, minute ventilation, inspiratory and expiratory duration, arterial pH, PaO2 and PaCO2 were measured respectively in room air, after 100% oxygen, in hypoxia (FIO2 = 0.12), before, 5 and 10 min after the injection of almitrine. Hyperoxia depressed ventilation (-21%), whilst hypoxia stimulated it (+126%), although significantly less than in the awake animal. Almitrine restored the respiratory response to hypoxia, but hyperoxia did not suppress respiratory stimulation due to the drug. It would therefore seem likely that almitrine acts on peripheral arterial chemoreceptors, but also on other structures. The results of this study suggest that almitrine may be useful in restoring the respiratory response to hypoxia during recovery from anaesthesia.
Gaudy
J H
JH
Laboratoire d'Anesthésiologie, Faculté de Médecine Saint-Antoine, Paris.
Sicard
J F
JF
Gateau
O
O
Farinotti
R
R
D015765:Almitrine / Q000494:pharmacology*; D000768:Anesthesia, General; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D002628:Chemoreceptor Cells / Q000187:drug effects*; D004195:Disease Models, Animal; D004285:Dogs; D000860:Hypoxia / Q000503:physiopathology; D008297:Male; D010100:Oxygen / Q000008:administration & dosage / Q000032:analysis*; D010102:Oxygen Inhalation Therapy; D012119:Respiration / Q000187:drug effects*; D013874:Thiopental
D002245:Carbon Dioxide; D015765:Almitrine; D013874:Thiopental; D010100:Oxygen
Effets ventilatoires de l'almitrine à différents niveaux de FIO2. Etude chez le chien anesthésié.